Cosmetic interventions need tighter controls to protect patients, review concludesBMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f2631 (Published 24 April 2013) Cite this as: BMJ 2013;346:f2631
- Ingrid Torjesen
The people and companies involved in surgical and non-surgical cosmetic interventions in England, including injection of dermal fillers and Botox, need to be more tightly regulated, the final report of a government commissioned review has said. And if things go wrong patients need to have a right of redress, it added.
The Department of Health commissioned the review, led by the NHS’s medical director, Bruce Keogh, last year, after serious problems arose with silicone breast implants made by the French company Poly Implant Prothèse (PIP).1
The review looked at the products used for surgical and non-surgical cosmetic procedures; the people who carry out the interventions; advertising; and the advice and support given to patients and consumers.2
It found that there is little or no regulation of non-surgical interventions such as injection of dermal fillers or Botox, despite their popularity. The review’s final report said that production of dermal fillers should be subject to the same controls …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial